How have ATRA and BMEA total returns compared?

Over the past 5 years, ATRA delivered -53.60% and BMEA delivered -36.56% annualized total return. Past performance doesn't predict future results.

Atara Biotherapeutics, Inc. (ATRA) vs Biomea Fusion, Inc. (BMEA)

A side-by-side comparison of Atara Biotherapeutics, Inc. and Biomea Fusion, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATRA

Atara Biotherapeutics, Inc.

$85M

$9.46HealthcareDelayed quote: Oct 6, 2026, 10:08 AM EDT

BMEA

Biomea Fusion, Inc.

$93M

$1.29HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ATRA vs BMEA

growth of $100 · dividends reinvested · last 5y

ATRA -97.3% (-51.4%/yr)BMEA -92.4% (-40.2%/yr)BMEA compounded faster over this window

ATRA BMEA

ATRA vs BMEA: by the numbers

•BMEA is the larger company ($93M vs $85M market cap).
•Both run net losses; BMEA's is the smaller (0.00% vs -269.42% net margin).

Metrics side by side

Valuation

Metric	ATRA	BMEA
P/S ratio	13.76	N/A
P/B ratio	N/A	7.65

Profitability

Metric	ATRA	BMEA
Gross margin	82.44%	0.00%
Operating margin	29.69%	0.00%
Net margin	-269.42%	0.00%
ROE	N/A	-268.09%
ROIC	-100.35%	-220.02%

Growth (annualized)

Metric	ATRA	BMEA
Revenue CAGR (5Y)	56.10%	N/A
Total return CAGR (5Y)	-53.60%	-36.56%

Frequently asked

How have ATRA and BMEA total returns compared?: Over the past 5 years, ATRA delivered -53.60% and BMEA delivered -36.56% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATRA analysis Full BMEA analysis Interactive comparison tool

Dig into the metrics

Atara Biotherapeutics ROE Biomea Fusion ROE Atara Biotherapeutics operating margin Biomea Fusion operating margin Atara Biotherapeutics revenue growth Biomea Fusion revenue growth Atara Biotherapeutics free cash flow Biomea Fusion free cash flow

Atara Biotherapeutics & Biomea Fusion appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.